Search for: "BRISTOL-MYERS SQUIBB COMPANY"
Results 121 - 140
of 472
Sort by Relevance
|
Sort by Date
17 Jul 2017, 2:03 pm
To address these issues and concerns head on, the New Jersey Association of Biomedical Research recently hosted one of the most significant efforts to promote biomedical research advocacy, the “Biomedical Research Summit,” presented by Bristol-Myers Squibb, also sponsored by Covance, Charles River Laboratories, s-tune software, Inc., Marshall BioResources, and Allentown, Inc. [read post]
3 Jul 2017, 6:15 am
In Bristol-Myers Squibb Company v. [read post]
29 Jun 2017, 2:29 pm
Seyfarth Synopsis: In Bristol-Myers Squibb Company v. [read post]
29 Jun 2017, 11:06 am
In Bristol-Myers Squibb Co. v. [read post]
29 Jun 2017, 11:06 am
In Bristol-Myers Squibb Co. v. [read post]
28 Jun 2017, 8:34 am
Ability’s manufacturers, Otsuka and Bristol-Myers Squibb, are facing a growing number of lawsuits from patients who claim they couldn’t control the urge to gamble or over-eat, or that they developed hyper sexual behaviors. [read post]
27 Jun 2017, 8:00 am
On June 19, 2017, the Supreme Court reinforced its narrow application of specific jurisdiction in mass tort proceedings in an 8-1 decision in Bristol-Myers Squibb Company v. [read post]
27 Jun 2017, 8:00 am
On June 19, 2017, the Supreme Court reinforced its narrow application of specific jurisdiction in mass tort proceedings in an 8-1 decision in Bristol-Myers Squibb Company v. [read post]
26 Jun 2017, 3:34 am
And tune in for our October 10 webcast – “E&S Disclosures: The In-House Perspective” – featuring experts from the Coca-Cola Company, Bristol-Myers Squibb, Apple & Clorox. [read post]
22 Jun 2017, 11:23 am
Bristol-Myers Squibb (“BMS”) objected to the exercise of personal jurisdiction over it with respect to the nonresident plaintiffs’ claims. [read post]
22 Jun 2017, 11:23 am
Bristol-Myers Squibb (“BMS”) objected to the exercise of personal jurisdiction over it with respect to the nonresident plaintiffs’ claims. [read post]
20 Jun 2017, 1:15 pm
Bristol-Myers Squibb Company v. [read post]
20 Jun 2017, 4:29 am
And in Bristol-Myers Squibb Co. v. [read post]
19 Jun 2017, 11:56 am
The court’s decision this morning in Bristol-Myers Squibb v. [read post]
24 May 2017, 7:38 am
” Bristol-Myers Squibb and Otsuka began marketing the drug in the US in 2002. [read post]
16 May 2017, 9:40 am
Otsuka and Bristol-Myers Squibb promoted Abilify for unapproved uses. [read post]
29 Apr 2017, 10:08 am
Wrendell Chester, from Texas, recently filed a personal injury and product liability lawsuit, against Bristol-Myers Squibb and AstraZeneca, the manufacturers of the drug. [read post]
12 Apr 2017, 2:22 pm
An Observational Study Compared Myocardial Infarction / Heart Attack Risks As Between The Use Of Newer Blood Thinners And The Use Of Warfarin (Posted by Tom Lamb at DrugInjuryWatch.com) In the US, there are currently four direct-acting oral anticoagulants (DOACs), a relatively new class of blood thinners, approved for the prevention of stroke in patients with atrial fibrillation (AF): Pradaxa (dabigatran) -- approved by FDA in 2010 -- Boehringer Ingelheim Pharmaceuticals Xarelto… [read post]
8 Mar 2017, 12:37 pm
Further, Defendant Bristol-Myers Squibb has its principal place of business in New York.... [read post]
23 Feb 2017, 7:21 am
As of December 2016, approximately 34 Eliquis lawsuits were pending against the drug’s manufacturers, Bristol-Myers Squibb and Pfizer, Inc. [read post]
